BeauCare Clinics Funding, Investors & Competitors

BeauCare Clinics has raised $118M across 3 funding rounds, most recently a $58M Series C in September 2018.

Last BeauCare Clinics funding round

$58M

Series C · Sep 2018

Cumulative funding BeauCare Clinics raised

$118M

across 3 funding rounds

Key investors in BeauCare Clinics

BeauCare Clinics Overview

About BeauCare Clinics

BeauCare Clinics is a network of over 30 plastic surgery and aesthetic centers operating in more than ten cities across China. Established in 2013, the clinics offer procedures such as nose reconstruction, facelifts, eyelid surgery, breast lifts, skin whitening, laser hair removal, and filler injections. Physicians hail from China, South Korea, Japan, and the United States.


Founded

2013

HQ

ChinaBeijing

Status

Privately held

Customer focus

B2C

Revenue model

Services

BeauCare Clinics Funding History

BeauCare Clinics has raised a total of $118M across 3 funding rounds.

BeauCare Clinics' first fundraising round was a $30M Series A in January 2016. The most recent completed round was a $58M Series C in September 2018.

BeauCare Clinics funding rounds

BeauCare Clinics funding rounds
DateStageInvestorsRaisedDeal Summary
Sep 2018Series CSino-Ocean Group Holding (lead); China Equity$58MThe company operates over 40 clinics across more than 15 cities in China, offering services including plastic surgery, micro-plastic surgery, skin beauty, anti-aging, ophthalmology, and postpartum rehabilitation, supported by a network of doctors from China, South Korea, Japan, and the US, with branch offices in San Francisco, Geneva, Vancouver, Seoul, Hong Kong, and Taiwan. Proceeds from the round were earmarked for further strategic expansion in the consumer medical market. The investment aligns with Sino-Ocean Capital's focus on health-related concepts and shared target markets in core cities and high-income customer groups, as noted by Lin Chuan, deputy general manager of Sino-Ocean Capital. This Series C followed prior rounds: RMB200 million (US$29 million) Series B in 2017 led by GP Capital, and RMB200 million (US$29 million) Series A in 2016 from undisclosed investors.
Jun 2017Series BGP Capital (lead)$29MBeauCare Clinics is a Beijing-based plastic surgery clinic franchise founded in 2013, operating over 40 clinics in more than 15 cities across China by 2018. The company offers plastic surgery, micro-plastic surgery, skin beauty, anti-aging, ophthalmology, and postpartum rehabilitation services, with a network of doctors from China, South Korea, Japan, and the US, and branch offices in San Francisco, Geneva, Vancouver, Seoul, Hong Kong, and Taiwan. In June 2017, BeauCare Clinics raised RMB200 million (US$29 million) in a Series B funding round led by GP Capital, a Shanghai-based investment firm backed by state-owned Shanghai International Group. This followed a Series A round of RMB200 million (US$29 million) in 2016 from undisclosed investors. Subsequently, in 2018, the company raised RMB400 million (US$58 million) in a Series C round from Sino-Ocean Capital, with proceeds intended for strategic expansion in the consumer medical market. Sources note total capital raised across rounds at approximately $118.7 million.
Jan 2016Series A-$30MBeauCare Clinics, a Beijing-based plastic surgery clinic franchise founded in 2013, raised RMB200 million (US$29 million) in a Series A funding round in 2016 from undisclosed investors. The company operates over 40 clinics in more than 15 cities across China, offering services including plastic surgery, micro-plastic surgery, skin beauty, anti-aging, ophthalmology, and postpartum rehabilitation. It maintains a network of doctors from China, South Korea, Japan, and the US, with branch offices in San Francisco, Geneva, Vancouver, Seoul, Hong Kong, and Taiwan. Following the Series A, BeauCare Clinics secured a RMB200 million (US$29 million) Series B round in 2017 led by GP Capital. In 2018, it raised RMB400 million (US$58 million) in a Series C round from Sino-Ocean Capital, with proceeds allocated to strategic expansion in the consumer medical market. The investor highlighted alignment in core brand concepts like 'health' and 'people-oriented' approaches, targeting core cities and high-income customer groups. BeauCare operates in China's rapidly growing medical aesthetics sector, though competitor So Young reported CNY 49 million revenue in 2016, providing indirect market context.

Who has invested in BeauCare Clinics?

3 investors have backed BeauCare Clinics across its funding rounds, including GP Capital, China Equity and Sino-Ocean Group Holding.

Lead investors include Sino-Ocean Group Holding and GP Capital.


BeauCare Clinics Investors

Investors in BeauCare Clinics by funding rounds participated
InvestorHQRoundsRoleFirst check
Sino-Ocean Group HoldingChinaChina1LeadSep 2018

This data is available for Pro users. Sign up to see all 3 BeauCare Clinics investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

BeauCare Clinics Competitors

BeauCare Clinics competitors include listed companies like Rollins, Madison Air, Service Corporation International and H&R Block, and private ones like Papa and Vagaro.

Public and private companies comparable to BeauCare Clinics
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
RollinsUnited StatesUnited StatesPublicly listed$3.8B$854M$16B4.2x
Madison AirUnited StatesUnited StatesPublicly listed$3.5B$697M$12B3.9x
Service Corporation InternationalUnited StatesUnited StatesPublicly listed$4.3B$1.3B$11B3.6x
H&R BlockUnited StatesUnited StatesPublicly listed$3.9B$1.1B$5.5B1.7x
PapaUnited StatesMiami, FLPrivate--$1.4B-
VagaroUnited StatesUnited StatesPrivate--$1B-

BeauCare Clinics Public Comps

BeauCare Clinics is still privately-owned, but its public comps include Rollins, Madison Air, Service Corporation International, H&R Block, Frontdoor, Bright Horizons Family, CVS Group, CEWE Group, XPS Pensions Group and Musti Group.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Rollins$3.8B$854M4.5x4.2x19.8x19.1x
Madison Air$3.5B$697M4.2x3.9x21.1x14.6x
Service Corporation International$4.3B$1.3B3.7x3.6x11.9x11.7x
H&R Block$3.9B$1.1B1.7x1.7x6.3x6.2x
Frontdoor$2.1B$484M2.9x2.8x12.5x10.4x
Bright Horizons Family$2.9B$408M1.8x1.7x12.6x10.2x
CVS Group$904M$152M1.7x1.6x10.0x8.0x
CEWE Group$1B$160M0.8x0.9x5.3x5.3x

This data is available for Pro users. Sign up to see all BeauCare Clinics competitors and their valuation data.

Start Free Trial

Common questions about BeauCare Clinics

When was BeauCare Clinics founded?BeauCare Clinics was founded in 2013.
Where is BeauCare Clinics headquartered?BeauCare Clinics is headquartered in Beijing, China.
Is BeauCare Clinics publicly listed?No, BeauCare Clinics is a private, VC-backed company.
How much funding has BeauCare Clinics raised?BeauCare Clinics has raised $118M across 3 funding rounds.
What was BeauCare Clinics' last funding round?BeauCare Clinics' last funding round was a $58M Series C in September 2018, led by Sino-Ocean Group Holding.
Who are BeauCare Clinics' investors?BeauCare Clinics' investors include Sino-Ocean Group Holding, GP Capital and China Equity.
Which companies are comparable to BeauCare Clinics?Companies comparable to BeauCare Clinics include Rollins, Madison Air, Service Corporation International, H&R Block, Papa and Vagaro.

See companies similar to BeauCare Clinics

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial